Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · IEX Real-Time Price · USD
0.182
+0.002 (0.83%)
At close: Apr 23, 2024, 4:00 PM
0.185
+0.004 (1.93%)
Pre-market: Apr 24, 2024, 4:00 AM EDT

MTNB Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current2023202220212020201920182017201620152014
Market Capitalization
464710821827136967108---
Market Cap Growth
--56.68%-50.35%-19.40%-26.65%452.45%-37.98%----
Enterprise Value
35378417321634655101-4-3-3
PE Ratio
-2.05-2.05-5.16-9.22-11.66-20.19-4.46-3.28---
PS Ratio
41.5442.8634.016618.49-------
PB Ratio
2.372.442.964.164.2511.184.1410.09---
P/FCF Ratio
-3.03-3.03-5.41-14.11-15.60-25.48-6.16-8.69---
P/OCF Ratio
-3.07-3.07-5.66-14.35-15.60-26.21-6.48-9.41---
EV/Sales Ratio
32.1833.5126.275255.79-------
EV/EBITDA Ratio
-1.67-1.67-4.17-7.71-9.96-20.83-3.81-6.390.550.360.26
EV/EBIT Ratio
-1.60-1.60-3.99-7.45-9.62-19.89-3.75-6.350.540.360.26
EV/FCF Ratio
-2.37-2.37-4.18-11.20-12.43-23.84-5.04-8.110.670.420.32
Debt / Equity Ratio
0.180.180.110.090.060.130.020.020.020.000.03
Debt / EBITDA Ratio
-0.16-0.16-0.21-0.21-0.17-0.25-0.03-0.02-0.020.00-0.01
Debt / FCF Ratio
-0.23-0.23-0.21-0.30-0.22-0.29-0.04-0.02-0.020.00-0.01
Quick Ratio
5.275.276.7211.4216.499.054.424.222.952.952.41
Current Ratio
5.935.938.0611.7317.259.664.614.503.163.152.51
Asset Turnover
0.030.030.0600000000
Return on Equity (ROE)
-89.20%-89.20%-50.70%-39.40%-32.90%-47.40%-126.40%-228.30%-207.80%-130.20%-185.50%
Return on Assets (ROA)
-72.20%-72.20%-41.90%-35.00%-30.10%-39.80%-96.90%-185.60%-143.50%-91.50%-158.20%
Return on Capital (ROIC)
-104.23%-104.23%-60.33%-43.25%-36.11%-50.99%-89.32%-152.12%-113.20%-166.12%-457.48%
Earnings Yield
-50.40%-48.84%-19.36%-10.84%-8.58%-4.95%-22.41%-30.45%---
FCF Yield
-34.04%-32.99%-18.49%-7.09%-6.41%-3.92%-16.24%-11.50%---
Buyback Yield / Dilution
-0.21%-0.21%-3.16%-6.75%-35.61%-48.00%-8.43%-56.93%-11.99%-60.49%-68.81%
Total Shareholder Return
-0.21%-0.21%-3.16%-6.75%-35.61%-48.00%-8.43%-56.93%-11.99%-60.49%-68.81%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).